The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Chemical Radiosensitizers for Use in Radiotherapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,484
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
The Chemical Basis of Radiation Biology
O'Neill, P. (1987) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553008714552571 · Cited by 1,835
The chemical basis of radiation biology
von Sonntag, C. (1987) · Medical Entomology and Zoology · Cited by 1,760
Griffith, O. W., & Meister, A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35980-5 · Cited by 1,683
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
Nitric oxide : biology and pathobiology
Ignarro, L. J. (2000) · Cited by 1,306
Disrupting tumour blood vessels
Tozer, G. M., Kanthou, C., & Baguley, B. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1628 · Cited by 930
Catalytic Metals, Ascorbate and Free Radicals: Combinations to Avoid
Buettner, G. R., & Jurkiewicz, B. A. (1996) · Radiation Research · doi:10.2307/3579271 · Cited by 887
Free-Radical-Induced DNA Damage and Its Repair: A Chemical Perspective
von Sonntag, C. (2006) · Springer eBooks · doi:10.1007/3-540-30592-0 · Cited by 808
Radiobiology for the Radiologist
Fowler, J. F., & Hall, E. J. (1988) · Radiation Research · doi:10.2307/3577489 · Cited by 785
Atmospheric Oxidation and Antioxidants
(1993) · Elsevier eBooks · doi:10.1016/c2009-0-15760-4 · Cited by 736
Mikkelsen, R. B., & Wardman, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206663 · Cited by 592
Self-citationLow-dose hypersensitivity: current status and possible mechanisms
Joiner, M. C., Marples, B., Lambin, P., Short, S. C., & Turesson, I. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01471-1 · Cited by 570
Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential
Ichinose, F., Roberts, J. D., & Zapol, W. M. (2004) · Circulation · doi:10.1161/01.cir.0000134595.80170.62 · Cited by 540
Steel, G. G. (1997) · Cited by 490
Calabrese, C. R., Almassy, R., Barton, S., Batey, M. A., Calvert, A. H., Canan-Koch, S., Durkacz, B. W., Hostomsky, Z., Kumpf, R. A., Kyle, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh005 · Cited by 487
The concurrent chemoradiation paradigm—general principles
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0714 · Cited by 443
Shafirovich, V., & Lymar, S. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112202099 · Cited by 439
Distribution of ascorbic acid, metabolites and analogues in man and animals
Hornig, D. (1975) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1975.tb29271.x · Cited by 438
Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
Overgaard, J., & Horsman, M. R. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80032-4 · Cited by 420
Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes
Harrison, L. B., Chadha, M., Hill, R. J., Hu, K., & Shasha, D. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-492 · Cited by 376
Hypoxia and Anemia: Factors in Decreased Sensitivity to Radiation Therapy and Chemotherapy?
Harrison, L., & Blackwell, K. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-31 · Cited by 349
Wouters, B. G., & Brown, J. M. (1997) · Radiation Research · doi:10.2307/3579620 · Cited by 341
Sulfur-Centered Reactive Intermediates in Chemistry and Biology
(1990) · Springer eBooks · doi:10.1007/978-1-4684-5874-9 · Cited by 336
Free-Radical-Induced DNA Damage and Its Repair: A Chemical Perspective
von Sonntag, C. (2005) · CERN Document Server (European Organization for Nuclear Research) · Cited by 332
How does radiation kill cells?
Cohen–Jonathan, E., Bernhard, E. J., & McKenna, W. G. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80014-3 · Cited by 328
Vascular‐targeting therapies for treatment of malignant disease
Siemann, D. W., Chaplin, D. J., & Horsman, M. R. (2004) · Cancer · doi:10.1002/cncr.20299 · Cited by 310
Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274
Radiation sensitizers, their use in the clinical management of cancer
Protectors, & Brady, L. W. (1980) · Masson Pub. USA eBooks · Cited by 273
Burkitt, M. J. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2509 · Cited by 266
ARCON: a novel biology-based approach in radiotherapy
Kaanders, J. H., Bussink, J., & van der Kogel, A. J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00929-4 · Cited by 256
Handbook of Metal-Ligand Interactions in Biological Fluids
Berthon, G. (1995) · Cited by 243
The Ras radiation resistance pathway.
Gupta, A. K., Bakanauskas, V. J., Cerniglia, G. J., Cheng, Y., Bernhard, E. J., Muschel, R. J., & McKenna, W. G. (2001) · PubMed · Cited by 238
The emerging role of reactive oxygen species in cancer therapy
Renschler, M. F. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.031 · Cited by 237
Adams, G. E., Clarke, E. D., Flockhart, I. R., Jacobs, R. S., Sehmi, D. S., Stratford, I. J., Wardman, P., Watts, M. E., Parrick, J., Wallace, R. G., et al. (1979) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553007914550151 · Cited by 236
Self-citationRadioprotection by antioxidants.
Weiss, J. F., & Landauer, M. R. (2000) · PubMed · Cited by 229
The redox potential of the system oxygen—superoxide
Wood, P. M. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80297-8 · Cited by 223
Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.
Overgaard, J. (1994) · PubMed · Cited by 218
Electron-affinic Sensitization: I. A Structural Basis for Chemical Radiosensitizers in Bacteria
Adams, G. E., & Cooke, M. S. (1969) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553006914550741 · Cited by 207
Radioprotection by Antioxidantsa
WEISS, J. F., & LANDAUER, M. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06175.x · Cited by 199
Biologic Basis for Combining Drugs With Radiation
WILSON, G., BENTZEN, S., & HARARI, P. (2006) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.001 · Cited by 198
O'Neill, P. (1983) · Radiation Research · doi:10.2307/3576178 · Cited by 188
Kashiwagi, S., Izumi, Y., Gohongi, T., Demou, Z. N., Xu, L., Huang, P. L., Buerk, D. G., Munn, L. L., Jain, R. K., & Fukumura, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24015 · Cited by 188
Oxygen inhibition of nitroreductase: Electron transfer from nitro radical-anions to oxygen
Wardman, P., & Clarke, E. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90464-2 · Cited by 183
Self-citationRadiosensitizers of hypoxic cells in solid tumours
Fowler, J. F., Adams, G. E., & Denekamp, J. (1976) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(76)80012-6 · Cited by 182
Brown, J. M., & Lemmon, M. J. (1990) · PubMed · Cited by 181
l-S,R-buthionine sulfoximine: historical development and clinical issues
Bailey, H. H. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00164-6 · Cited by 178
Koch, C., Evans, S., & Lord, E. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.426 · Cited by 178
CHEMICAL RADIOSENSITIZATION OF HYPOXIC CELLS
ADAMS, G. E. (1973) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070956 · Cited by 176
Hypoxic mammalian cell radiosensitization by nitric oxide.
Mitchell, J. B., Wink, D. A., DeGraff, W., Gamson, J., Keefer, L. K., & Krishna, M. C. (1993) · PubMed · Cited by 173
Adams, G. E., Asquith, J. C., Dewey, D. L., Foster, J. L., Michael, B. D., & Willson, R. L. (1971) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553007114550751 · Cited by 173
Anemia, tumor hypoxemia, and the cancer patient
Varlotto, J., & Stevenson, M. A. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.04.049 · Cited by 173
Carboplatin as a potentiator of radiation therapy
Douple, E. B., Richmond, R. C., O'Hara, J. A., & Coughlin, C. T. (1985) · Cancer Treatment Reviews · doi:10.1016/0305-7372(85)90026-x · Cited by 169
Hypoxia in head and neck cancer: How much, how important?
Janssen, H. L., Haustermans, K. M., Balm, A. J., & Begg, A. C. (2005) · Head & Neck · doi:10.1002/hed.20223 · Cited by 169
Hicks, K. O., Pruijn, F. B., Secomb, T. W., Hay, M. P., Hsu, R., Brown, J. M., Denny, W. A., Dewhirst, M. W., & Wilson, W. R. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj306 · Cited by 168
McGinn, C. J., Shewach, D. S., & Lawrence, T. S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1193 · Cited by 165
Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan
Bailey, H. H., Ripple, G., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Mahvi, D., Schink, J., Pomplun, M., Mulcahy, R. T., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1789 · Cited by 164
Motexafin gadolinium: A novel redox active drug for cancer therapy
Magda, D., & Miller, R. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.002 · Cited by 162
Laderoute, K., Wardman, P., & Rauth, A. M. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90010-x · Cited by 158
Self-citationWardman, P. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372959 · Cited by 150
Self-citationEffect of Nitric Oxide on the Radiosensitivity of Bacteria
Howard-Flanders, P. (1957) · Nature · doi:10.1038/1801191a0 · Cited by 149
Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs
Kinsella, T. J., Dobson, P. P., Mitchell, J. B., & Fornace, A. J. (1987) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(87)90292-6 · Cited by 146
Raleigh, J. A., Dewhirst, M. W., & Thrall, D. Ε. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80034-8 · Cited by 145
Treatment of cancer with radiation and drugs.
Tannock, I. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3156 · Cited by 135
Williams, K. J., Telfer, B. A., Brave, S. R., Kendrew, J., Whittaker, L., Stratford, I. J., & Wedge, S. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1147 · Cited by 134
Cook, T., Wang, Z., Alber, S. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2212 · Cited by 127
Tirapazamine: a hypoxia-activated topoisomerase II poison.
Peters, K. B., & Brown, J. M. (2002) · PubMed · Cited by 117
Choudhury, A., Cuddihy, A. R., & Bristow, R. G. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.007 · Cited by 110
Jordan, B. F., Grégoire, V., Demeure, R., Sonveaux, P., Féron, O., O’Hara, J. A., Vanhulle, V. P., Delzenne, N. M., & Gallez, B. (2002) · PubMed · Cited by 107
The Role of Topotecan in the Treatment of Brain Metastases
Wong, E. T., & Berkenblit, A. (2004) · The Oncologist · doi:10.1634/theoncologist.9-1-68 · Cited by 107
Abraham, D. J., Wireko, F. C., Randad, R. S., Poyart, C., KISTER, J., Brohard-Bohn, B., Liard, J. F., & Kunert, M. P. (1992) · Biochemistry · doi:10.1021/bi00153a005 · Cited by 105
Current status of angiogenesis inhibitors combined with radiation therapy
Nieder, C., Wiedenmann, N. E., Andratschke, N. H., & Molls, M. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.03.006 · Cited by 104
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study
Ng, Q., Goh, V., Milner, J., Stratford, M. R. L., Folkes, L. K., Tozer, G. M., Saunders, M. I., & Hoskin, P. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70001-3 · Cited by 102
An Experimental and Analytical Study of Oxygen Depletion in Stirred Cell Suspensions
Whillans, D. W., & Rauth, A. M. (1980) · Radiation Research · doi:10.2307/3575221 · Cited by 98
Time-Resolved Oxygen Effects in Irradiated Bacteria and Mammalian Cells: A Rapid-Mix Study
Shenoy, M. A., Asquith, J. C., ADAMS, G. E., Michael, B. D., & Watts, M. E. (1975) · Radiation Research · doi:10.2307/3574143 · Cited by 96
Jonathan, R. A., Wijffels, K. I. E. M., Peeters, W. J. M., de Wilde, P. C. M., Marres, H. A. M., Merkx, M. A. W., Oosterwijk, E., van der Kogel, A. J., & Kaanders, J. H. A. M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.04.008 · Cited by 95
Cellular Uptake of Misonidazole and Analogues with Acidic or Basic Functions
Dennis, M. F., Stratford, M. R. L., Wardman, P., & Watts, M. E. (1985) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008514550871 · Cited by 92
Self-citationHypoxia in head and neck cancer
Isa, A., Ward, T. H., West, C., Slevin, N. J., & Homer, J. J. (2006) · British Journal of Radiology · doi:10.1259/bjr/17904358 · Cited by 91
Clinical studies of hypoxia modification in radiotherapy
Kaanders, J. H. A. M., Bussink, J., & van der Kogel, A. J. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.002 · Cited by 91
Koch, C. J. (1984) · Radiation Research · doi:10.2307/3576294 · Cited by 89
Liao, Z. X., Komaki, R. U., Milas, L., Yuan, C., Kies, M. S., Chang, J. Y., Jeter, M. D., Guerrero, T. M., Blumenschien, G., Smith, C. M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1741 · Cited by 86
Patterson, L. H., Ruparelia, K. C., McKeown, S. R., Double, J. A., Bibby, M. C., Cole, S., & Stratford, I. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1163 · Cited by 84
Chapman, J. D., Webb, R. G., & Borsa, J. (1971) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007114550741 · Cited by 83
Ahn, G., Botting, K. J., Patterson, A. V., Ware, D. C., Tercel, M., & Wilson, W. R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.007 · Cited by 81
Radiation Combined With EGFR Signal Inhibitors: Head and Neck Cancer Focus
Harari, P. M., & Huang, S.-F. K. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.005 · Cited by 80
Enhancement of Misonidazole Radiosensitization by an Inhibitor of Glutathione Biosynthesis
Hodgkiss, R. J., & Middleton, R. W. (1983) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008314550201 · Cited by 80
Therapeutic targets in radiotherapy
Brown, J. M. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01482-6 · Cited by 80
Survival measurements at low doses: oxygen enhancement ratio
Palcic, B., Brosing, J. W., & Skarsgard, L. D. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.312 · Cited by 78
Hypoxia-mediated druGS FOR RADIATION AND CHEMOTHERAPY
ADAMS, G. E. (1981) · Cancer · Cited by 77
Kyle, A. H., & Minchinton, A. I. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050886 · Cited by 75
Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells
Foster, J. L., Conroy, P. J., Searle, A., & WILLSON, R. L. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.78 · Cited by 74
Raju, U., Ariga, H., Dittmann, K., Nakata, E., Ang, K. K., & Milas, L. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.007 · Cited by 72
Saunders, M. I., & Dische, S. (1996) · Europe PMC (PubMed Central) · Cited by 69
Clinical Radiosensitization: Why It Does and Does Not Work
Coleman, C. N., & Mitchell, J. B. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.1 · Cited by 69
ATM as a target for novel radiosensitizers
Sarkaria, J. N., & Eshleman, J. S. (2001) · Seminars in Radiation Oncology · doi:10.1053/srao.2001.26030 · Cited by 69
Wardman, P. (1991) · Free Radical Research Communications · doi:10.3109/10715769109088942 · Cited by 68
Self-citationSkin sensitization by misonidazole: A demonstration of uniform mild hypoxia
Stewart, F. A., Denekamp, J., & Randhawa, V. S. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.139 · Cited by 65
Itani, W., Geara, F. B., Haykal, J., et al. (2007) · Radiation Oncology · doi:10.1186/1748-717x-2-1 · Cited by 63
Radiosensitization by Nitric Oxide at Low Radiation Doses
Wardman, P., Rothkamm, K., Folkes, L. K., Woodcock, M., & Johnston, P. J. (2007) · Radiation Research · doi:10.1667/rr0827.1 · Cited by 61
Self-citationRadiation and chemotherapy sensitizers and protectors
Coleman, C. N., & Turrisi, A. T. (1990) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(90)90033-o · Cited by 60
Chemical modifiers of radiosensitivity-theory and reality: A review
Fowler, J. F. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90296-2 · Cited by 60
Chapman, J. D., Schneider, R. F., Urbain, J.-L., & Hanks, G. E. (2001) · Seminars in Radiation Oncology · doi:10.1053/srao.2001.18103 · Cited by 59
Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy
Hoskin, P., Saunders, M. I., Phillips, H., Cladd, H., Powell, M., Goodchild, K., Stratford, M. R. L., & Rojas, A. M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.372 · Cited by 59
Radiation and New Molecular Agents, Part II: Targeting HDAC, HSP90, IGF-1R, PI3K, and Ras
Chinnaiyan, P., Allen, G., & Harari, P. M. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.008 · Cited by 57
Design of Hypoxia-Targeting Drugs as New Cancer Chemotherapeutics
Nagasawa, H., Uto, Y., Kirk, K. L., & Hori, H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.2335 · Cited by 57
Bernier, J., Denekamp, J., Rojas, A., Minatel, E., Horiot, J. C., Hamers, H. P., Antognoni, P., Dahl, O., Richaud, P. M., Glabbeke, M. M. V., et al. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00165-1 · Cited by 57
Glutathione depletion in tissues after administration of buthionine sulphoximine
Minchinton, A. I., Rojas, A., Smith, K. A., Soranson, J. A., Shrieve, D. C., Jones, N. R., & Bremner, J. C. M. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90329-8 · Cited by 55
Recent developments in the design of bioreductive drugs.
Denny, W. A., Wilson, W. R., & Hay, M. P. (1996) · Europe PMC (PubMed Central) · Cited by 54
Yang, L.-X., Douple, E. B., O’Hara, J. A., & Wang, H.-J. (1995) · Radiation Research · doi:10.2307/3579218 · Cited by 54
Marples, B., Joiner, M. C., & Skov, K. A. (1994) · Radiation Research · doi:10.2307/3578752 · Cited by 53
Radiation sensitization with redox modulators: A promising approach
Rosenberg, A. R., & Knox, S. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.013 · Cited by 52
Effect of Nitric Oxide on the Radio-sensitivity of Tumour Cells
Gray, L. H., Green, F. O., & Hawes, C. (1958) · Nature · doi:10.1038/182952a0 · Cited by 50
Pre- and post-irradiation adiosensitization by SR 4233
Zeman, E. M., & Brown, J. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90897-3 · Cited by 48
Dobrowsky, W., Huigol, N., Jayatilake, R., Kizilbash, N.-I.-A., Okkan, S., Kagiya, V. T., & Tatsuzaki, H. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.11.007 · Cited by 47
Potentiation of radiation‐induced regrowth delay by isosorbide dinitrate in FSaII murine tumors
Jordan, B. F., Beghein, N., Aubry, M., Grégoire, V., & Gallez, B. (2002) · International Journal of Cancer · doi:10.1002/ijc.10786 · Cited by 46
Thomson, P., Naylor, M. A., Everett, S. A., Stratford, M. R. L., Lewis, G., Hill, S. A., Patel, K. B., Wardman, P., & Davis, P. D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0429 · Cited by 46
Self-citationJordan, B. F., Sonveaux, P., Féron, O., Grégoire, V., Beghein, N., & Gallez, B. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04505-4 · Cited by 46
Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer
Zhu, A. X., & Willett, C. G. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00048-1 · Cited by 44
Targeting DNA mismatch repair for radiosensitization
Berry, S. E., & Kinsella, T. J. (2001) · Seminars in Radiation Oncology · doi:10.1053/s1053-4296(01)80067-9 · Cited by 43
Recent Advances in Bioreductive Drug Targeting
Naylor, M. A., & Thomson, P. (2001) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557013407241 · Cited by 42
McCarthy, H. O., Worthington, J., Barrett, E., Cosimo, E., Boyd, M., Mairs, R., Ward, C., McKeown, S. R., Hirst, D. G., & Robson, T. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302871 · Cited by 42
Hyperbaric oxygen for delayed radiation injuries.
Feldmeier, J. J. (2004) · PubMed · Cited by 42
Ahn, G., Ware, D. C., Denny, W. A., & Wilson, W. R. (2004) · Radiation Research · doi:10.1667/rr3229 · Cited by 42
Novel radiation sensitizers targeting tissue hypoxia.
Ravaud, A., Borner, M., Schellens, J. H. M., Geoffrois, L., Schöffski, P., Wanders, J., & Hanauske, A. R. (1999) · PubMed · Cited by 42
Shan, S., Rosner, G., Braun, R., Hahn, J. S., Pearce, C., & Dewhirst, M. W. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.406 · Cited by 41
Nitric oxide in tumour biology and cancer therapy. Part 1: Physiological aspects
Tozer, G. M., & Everett, S. A. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(05)80061-5 · Cited by 38
Saunders, M. I., Hoskin, P., Piggot, K., Powell, M. E. B., Goodchild, K., Dische, S., Denekamp, J., Stratford, M. R. L., Dennis, M. F., & Rojas, A. M. (1997) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00151-5 · Cited by 38
Sensitizers and protectors of radiation and chemotherapy
Poggi, M. M., Coleman, C. N., & Mitchell, J. B. (2001) · Current Problems in Cancer · doi:10.1067/mcn.2001.120122 · Cited by 36
Collingridge, D. R., & Rockwell, S. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001020)90:5<256::aid-ijc2>3.0.co;2-r · Cited by 36
Improving Chemoradiotherapy in Rectal Cancer
Glynne‐Jones, R., & Debus, J. (2001) · The Oncologist · doi:10.1634/theoncologist.6-2004-29 · Cited by 36
Raising Hemoglobin: An Opportunity for Increasing Survival?
Thomas, G. (2002) · Oncology · doi:10.1159/000067148 · Cited by 35
Evaluation of the “radical sink” hypothesis from a chemical-kinetic viewpoint
Wardman, P. (1998) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/bf02383706 · Cited by 34
Self-citationBamatraf, M. M. M., O'Neill, P., & Rao, B. S. M. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9823161 · Cited by 32
Koch, C. J., Oprysko, P. R., Shuman, A. L., Jenkins, W. T., Brandt, G., & Evans, S. M. (2002) · PubMed · Cited by 32
Seo, Y., Yan, T., Schupp, J. E., Colussi, V., Taylor, K., & Kinsella, T. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1144 · Cited by 31
Kinnaert, E., Duez, P., Morandini, R., Dubois, J., Houtte, P. V., & Ghanem, G. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00146.x · Cited by 30
Feasibility of Photofrin II as a Radiosensitizing Agent in Solid Tumors – Preliminary Results
Schaffer, M., Ertl-Wagner, B. B., Schaffer, P. M., Kulka, U., Jori, G., Wilkowski, R., Hofstetter, A., & Dühmke, E. (2006) · Oncology Research and Treatment · doi:10.1159/000095979 · Cited by 29
Nitric Oxide, Cell Signaling, and Gene Expression
Lamas, S. (2005) · CRC Press eBooks · doi:10.1201/9781420027167 · Cited by 28
Sunamura, M., Karasawa, K., Okamoto, A., Ogata, Y., Nemoto, K., Hosotani, R., Nishimura, Y., Matsui, K., & Matsuno, S. (2004) · Pancreas · doi:10.1097/00006676-200404000-00023 · Cited by 28
Platinum-Based Concurrent Chemoradiotherapy for Tumors of the Head and Neck and the Esophagus
Hao, D., RITTER, M., OLIVER, T., & Browman, G. P. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.002 · Cited by 28
Hoskin, P., Rojas, A. M., Phillips, H., et al. (2005) · Cancer · doi:10.1002/cncr.21048 · Cited by 27
Priyadarsini, K. I., Tracy, M., & Wardman, P. (1996) · Free Radical Research · doi:10.3109/10715769609149061 · Cited by 27
Self-citationEffects of texaphyrins on the oxygenation of EMT6 mouse mammary tumors
Donnelly, E. T., Liu, Y., Fatunmbi, Y. O., Lee, I., Magda, D. J., & Rockwell, S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)02447-7 · Cited by 26
Aerobic radiosensitization by sr 4233 in vitro and in vivo
Zeman, E. M., Lemmon, M. J., & Brown, J. M. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90276-p · Cited by 26
Bremner, J. C. M. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00689809 · Cited by 26
Vukovic, V., Nicklee, T., & Hedley, D. W. (2000) · PubMed · Cited by 26
Structure-Based Identification of Novel Human γ-Glutamylcysteine Synthetase Inhibitors
Hamilton, D., Wu, J. H., & Batist, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.024778 · Cited by 26
Measurement of extravascular drug diffusion in multicellular layers.
Wilson, W. R., & Ko, H. (1999) · PubMed · Cited by 26
Miyamoto, S., Huang, T. T., Wuerzberger‐Davis, S. M., Bornmann, W. G., Pink, J. J., Tagliarino, C., Kinsella, T. J., & Boothman, D. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb07045.x · Cited by 25
Vukovic, V. M., Nicklee, T., & Hedley, D. W. (2001) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(01)00331-0 · Cited by 24
Yang, L.-X., Douple, E. B., O’Hara, J. A., Crabtree, R. A., & Eastman, A. R. (1995) · Radiation Research · doi:10.2307/3579263 · Cited by 24
Cengel, K. A., & McKenna, W. G. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.02.001 · Cited by 23
Novel Radiation-Enhancing Agents in Malignant Gliomas
Zhang, M., & Chakravarti, A. (2005) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2005.08.004 · Cited by 23
Ridder, M. D., Verovski, V. N., Chiavaroli, C., den Berge, D. L. V., Monsaert, C., Ka, L. L., & Storme, G. A. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.1381 · Cited by 22
Tirapazamine Administered as a Neoadjuvant to Radiotherapy Reduces Metastatic Dissemination
Lunt, S. J., Telfer, B. A., Fitzmaurice, R. J., Stratford, I. J., & Williams, K. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2162 · Cited by 22
Hoogsteen, I. J., Pop, L. A. M., Marres, H. A. M., Merkx, M. A. W., van den Hoogen, F. J. A., van der Kogel, A. J., & Kaanders, J. H. A. M. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.003 · Cited by 21
Radiosensitizer-DNA interactions in relation to intracellular uptake
Stratford, M. R. L., Dennis, M. F., Watts, M. E., et al. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90904-8 · Cited by 21
Nitric oxide in tumour biology and cancer therapy. Part 2: Therapeutic implications
Tozer, G. M., & Everett, S. A. (1997) · Clinical Oncology · doi:10.1016/s0936-6555(97)80128-8 · Cited by 20
Hodgkiss, R. J., & Stratford, M. R. L. (1988) · International Journal of Radiation Biology · doi:10.1080/09553008814552041 · Cited by 16
Inhaled nitric oxide does not reduce systemic vascular resistance in mice
Hataishi, R., Zapol, W. M., Bloch, K. D., & Ichinose, F. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00938.2005 · Cited by 16
Kriste, A. G., Tercel, M., Anderson, R. F., Ferry, D. M., & Wilson, W. R. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0753:porfoh]2.0.co;2 · Cited by 16
Shih, S., Erbele, T., & Chen, A. Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2387 · Cited by 13
Limited Role of Vasculature-Mediated Injury in Tumor Response to Radiotherapy
Denekamp, J. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.935 · Cited by 10
Erythropoietin: effects on life expectancy in patients with cancer-related anaemia
Aapro, M., & Vaupel, P. W. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x159579 · Cited by 3
Cited by
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Graves, D. B. (2012) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/45/26/263001 · Cited by 1,518
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Biological Consequences of Radiation-induced DNA Damage: Relevance to Radiotherapy
Lomax, M. E., Folkes, L. K., & O'Neill, P. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.007 · Cited by 738
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Chen, Q., Chen, J., Yang, Z., Xu, J., Xu, L., Liang, C., Han, X., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201802228 · Cited by 661
Metadata
- Authors
- Wardman, P.
- Venue
- Clinical Oncology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 19
- Issue
- 6
- Pages
- 397-417
- ISSN
- 0936-6555 (ISSN-L)
- OpenAlex
- W2156311525
- Cited by
- 447
- References
- 168
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.